Responder analysis, comparing RP-G28 group to placebo group, based on numbers (percent)
of subjects achieving a 50% reduction in symptoms (total and individual scores, 6 hours)
at Day 36 compared with the baseline lactose challenge and at Day 66 compared with
the baseline lactose challenge